PMS-SALBUTAMOL 2 MG
SALBUTAMOL (SALBUTAMOL SULFATE) : 2 MG · DIN 02208237 · PHARMASCIENCE INC
Health Canada status: MARKETED
What is PMS-SALBUTAMOL?
PMS-SALBUTAMOL 2 MG contains SALBUTAMOL (SALBUTAMOL SULFATE) : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02208237, held by PHARMASCIENCE INC, supplied as SOLUTION for INHALATION administration. Health Canada currently lists it as marketed, status dated 07-May-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PMS-SALBUTAMOL used for?
Treatment of severe bronchospasm associated with exacerbations of chronic bronchitis and bronchial asthma. Used by “wet” nebulization.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is PMS-SALBUTAMOL called?
The same molecule, SALBUTAMOL, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| DILATOR | Latin | Morocco |
| Ventolin | Latin | Australia, Czechia, Saudi Arabia, Slovakia |
| VENTOLINE | Latin | Morocco |
| BUTAMYL | Latin | Morocco |
| BUVENTOL EASYHALER | Latin | Czechia |
| Ventolin Nebules | Latin | Australia |
| BULMOL | Latin | Morocco |
| INALER | Latin | Morocco |
| Salbutamol Cipla | Latin | Australia |
| Airomir Autohaler | Latin | Australia, South Africa |
| Asthavent Ecohaler | Latin | South Africa |
| Asthavent Syrup | Latin | South Africa |
| BUTOVENT | Latin | Morocco |
| DILATOR ECOSPRAY | Latin | Morocco |
| MAGISTRAL | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02208237 |
|---|---|
| Brand name | PMS-SALBUTAMOL |
| Generic / active ingredient | SALBUTAMOL (SALBUTAMOL SULFATE) : 2 MG |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 2 MG |
| Dosage form | SOLUTION |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | R03AC02 SALBUTAMOL |
| AHFS class | 84:04.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 07-May-2010 |
| Original market date | 1998-11-03 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02208237 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2208237 |
| Brand name | PMS-SALBUTAMOL |
| Active ingredient / INN | SALBUTAMOL (SALBUTAMOL SULFATE) : 2 MG |
| ATC code | R03AC02 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R03 |
| AHFS class | 84:04.04 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | PHARMASCIENCE INC |
How is it administered?
Adults/Adolescents (≥13): 2.5 mg via nebulizer every 4-6 hours as needed (max 4x/day). Children (5-12): 1.25 mg to 2.5 mg every 4-6 hours as needed (max 4x/day).
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
null
How is it supplied?
Polynebs (unit dose) in 0.5 mg/mL, 1 mg/mL, and 2 mg/mL strengths.
Which pack is which?
| Strength on the label | 2 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INHALATION |
| Packaging as described in the monograph | Polynebs (unit dose) in 0.5 mg/mL, 1 mg/mL, and 2 mg/mL strengths. |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Contraindications
Hypersensitivity to the drug or ingredients; tachyarrythmias; as a tocolytic in patients at risk of premature labour or threatened abortion.
Warnings and precautions
Potential for paradoxical bronchospasm, cardiovascular effects (hypertension, arrhythmias), hypokalemia, and metabolic changes (hyperglycemia, lactic acidosis).
Is SALBUTAMOL in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code R03AC02 SALBUTAMOL. 11 of 63 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-SALBUTAMOL HFA | 100 MCG | METERED-DOSE AEROSOL | APOTEX INC | MARKETED | DIN 02245669 |
| PMS-SALBUTAMOL | 0.5 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | DIN 02208245 |
| PMS-SALBUTAMOL | 1 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | DIN 02208229 |
| SALBUTAMOL HFA | 100 MCG | METERED-DOSE AEROSOL | SANIS HEALTH INC | MARKETED | DIN 02419858 |
| TEVA-SALBUTAMOL HFA | 100 MCG | METERED-DOSE AEROSOL | TEVA CANADA LIMITED | MARKETED | DIN 02326450 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED | DIN 01926934 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED | DIN 02173360 |
| VENTOLIN DISKUS | 200 MCG | POWDER | GLAXOSMITHKLINE INC | MARKETED | DIN 02243115 |
| VENTOLIN HFA | 100 MCG | METERED-DOSE AEROSOL | GLAXOSMITHKLINE INC | MARKETED | DIN 02241497 |
| VENTOLIN RESPIRATOR SOLUTION | 5 MG | SOLUTION | GLAXOSMITHKLINE INC | MARKETED | DIN 02213486 |
Who else supplies SALBUTAMOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SALBUTAMOL appears in 2807 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does SALBUTAMOL cost around the world?
SALBUTAMOL is listed on 16 national price registers Nexara tracks, across 165 pack listings published on 16 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Saudi Arabia | public | 39 | 42 | 01 Sep 2026 |
| Morocco | PPV (public price) | 13 | 34 | 05 Sep 2026 |
| South Africa | single exit price | 25 | 31 | 01 Sep 2026 |
| Australia | ex-manufacturer | 8 | 17 | 08 Sep 2026 |
| Czechia | max producer price (ex-factory) | 4 | 9 | 03 Sep 2026 |
| Romania | max producer price | 6 | 6 | 03 Sep 2026 |
| Austria | KVP (Kassenverkaufspreis) | 5 | 5 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 5 | 5 | 03 Sep 2026 |
| United Kingdom | hospital | 4 | 4 | 31 Aug 2026 |
| Luxembourg | reimbursement | 3 | 3 | 05 Sep 2026 |
| Bahrain | retail (max) | 2 | 2 | 01 Sep 2026 |
| Spain | PVP con IVA (public price) | 2 | 2 | 05 Sep 2026 |
| Sweden | AIP (pharmacy purchase price) | 2 | 2 | 03 Sep 2026 |
| Iceland | max wholesale | 1 | 1 | 02 Sep 2026 |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | 02 Sep 2026 |
| Slovakia | categorised final price | 1 | 1 | 02 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.